Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-11-08
2009-02-03
Tsang, Cecilia J. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07485618
ABSTRACT:
The present invention provides peptides and supported peptides that bind to FGF-5.
REFERENCES:
patent: 3755560 (1973-08-01), Dickert et al.
patent: 3929678 (1975-12-01), Laughlin et al.
patent: 4152416 (1979-05-01), Spitzer et al.
patent: 4421769 (1983-12-01), Dixon et al.
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4937370 (1990-06-01), Sabatelli
patent: 4965188 (1990-10-01), Mullis et al.
patent: 4999186 (1991-03-01), Sabatelli et al.
patent: 5011681 (1991-04-01), Ciotti et al.
patent: 5073371 (1991-12-01), Turner et al.
patent: 5073372 (1991-12-01), Turner et al.
patent: 5087372 (1992-02-01), Toyomoto et al.
patent: 5322770 (1994-06-01), Gelfand
patent: 5827508 (1998-10-01), Tanner et al.
patent: 5935556 (1999-08-01), Tanner et al.
patent: 5968485 (1999-10-01), Robinson
patent: 5972316 (1999-10-01), Robinson
patent: 6417327 (2002-07-01), Oka et al.
patent: 2002/0001825 (2002-01-01), Itoh
patent: 2004/0031072 (2004-02-01), La Rosa et al.
patent: 2004/0034888 (2004-02-01), Liu et al.
patent: 2004/0123343 (2004-06-01), La Rosa et al.
patent: WO 96/03964 (1996-02-01), None
patent: WO 96/16636 (1996-06-01), None
patent: WO 97/38708 (1997-10-01), None
patent: WO 98/22085 (1998-05-01), None
patent: WO 00/06110 (2000-02-01), None
patent: WO 00/24372 (2000-05-01), None
patent: WO02094867 (2002-11-01), None
Suzuki et al. “Dual-Mode Regulation of Hair Growth Cycle by Two Fgf-5 Gene Products,” J. Invest. Derm. 2000, 114, 456-63.
Ito et al. “Decapeptide with fibroblast growth factor (FGF)-5 partial sequence inhibits hair growth suppressing activity of FGF-5,” J. Cell. Phys. 2003, 197, 272-83.
Terao et al. “Purification of the aldehyde oxidase homolog 1 (AOH1) protein and cloning of the AOH1 and aldehyde oxidase homolog 2 (AOH2) genes: identification of a novel molybdo-flavoprotein gene cluster on mouse chromosome,” J. Biol. Chem., 2001, 276, 46347-63.
Young et al. “Sequence, localization and function of the invasin protein of Yersinia enterocolitica,” Mol. Microbiol., 1990. 4, 1119-28.
Kaneko et al. “Complete genomic sequence of nitrogen-fixing symbiotic bacterium Bradyrhizobium japonicum USDA110,” DNA Res., 2002, 9, 189-97.
Nakamura et al. “Complete genome structure of the thermophilic cyanobacterium Thermosynechococcus elongatus BP-1,” DNA Res., 2002, 9, 123-30.
Albrecht “Primary structure of the herpesvirus Ateles genome,” J. Virol., 2000, 74, 1033-7.
CAPLUS abstract accession No. 1991:157829.
CAPLUS abstract accession No. 2002:906291.
CAPLUS abstract accession No. 2004:663852.
CAPLUS abstract accession No. 2004:260860.
CAPLUS abstract accession No. 2004:155818.
CAPLUS abstract accession No. 2003:130926.
CAPLUS abstract accession No. 2002:700127.
CAPLUS abstract accession No. 2000:42494.
Altschul et al., “Basic Local Alignment Search Tool,”J. Mol. Biol., 215:403-410 (1990).
Beaucage et al., “Deoxynucleoside Phosphoramidites—A New Class of Key Intermediates for Deoxypolynucleotide Synthesis,”Tetrahedron Letters, 22(20):1859-1862 (1981).
Bode et al., “Natural Protein Proteinase Inhibitors and Their Interaction with Proteinases,”Eurl. J. Biochem., 204:433-451 (1992).
Chen et al., “Reactive Sites of an Anticarcinogenic Bowman-Birk Proteinase Inhibitor are Similar to Other Trypsin Inhibitors,”The Journal of Biological Chemistry, 267(3):1990-1994 (1992).
Chou et al., “Non-Selective Inhibition of Transformed Cell Growth by a Protease Inhibitor,”Proc. Nat. Acad. Sci. USA, 71(5):1748-1752 (1974).
CTFA, International Cosmetic Ingredient Dictionary and Handbook, 10th Edition 2004, vol. 2, pp. 1026-1028 and 1103 (1995).
Devereaux et al., “A Comprehensive Set of Sequence Analysis Programs for the VAX,” 12(1):387-395 (1984).
Hebert et al., “FGF5 as a Regulator of the Hair Growth Cycle: Evidence from Targeted and Spontaneous Mutations,”Cell, 78:1017-1025 (1994).
Henikoff et al., “Amino Acid Substitution Matrices from Protein Blocks,”Proc. Natl. Acad. Sci. USA, 89:10915-10919 (1992).
Higgins et al., “CLUSTAL: a Package for Performing Multiple Sequence Alignment on a Microcomputer,”Gene, 73:237-244 (1988).
Ito et al., “Decapeptide with Fibroblast Growth Factor (FGF)-5 Partial Sequence Inhibits Hair Growth Suppressing Activity of FGF-5,”Journal of Cellular Physiology, 197:272-283 (2003).
Karlin et al., “Applications and Statistics for Multiple High-scoring Segments in Molecular Sequences,”Proc. Natl. Acad. Sci. USA, 90:5873-5877 (1993).
Laskowski et al., “Protein Inhibitors of Proteinases,”Ann. Rev. Biochem., 49:593-626 (1980).
Lin et al., “The 0.25-nm X-ray Structure of the Bowman-Birk-type Inhibitor from Mung Bean in Ternary Complex with Porcine Trypsin,”Eur. J. Biochem., 212:549-555 (1993).
Liu, KeShun,Soybeans Chemistry, Technology, and Utilization, pp. 32-35, Aspen Publishers, Inc., Gaithersburg, Maryland (1999).
Livingstone et al., “Protein Sequence Alignments: a Strategy for the Hierarchical Analysis of Residue Conservation,”CABIOS, 9(6):745-756 (1993).
Matthes et al., “Simultaneous Rapid Chemical Synthesis of Over One Hundred Oligonucleotides on a Microscale,”The EMBO Journal, 3(4):801-805 (1984).
Morinaga et al., “Improvement of Oligonucleotide-Directed Site-Specific Mutagenesis Using Double-Stranded Plasmid DNA,”Biotechnology, 2:636-639 (1984).
Nelson et al., “A General Method of Site-Specific Mutagenesis Using a Modification of theThermusAquaticus Polymerase Chain Reaction,”Analytical Biochemistry, 180:147-151 (1989).
Pearson et al., “Improved Tools for Biological Sequence Comparison,”Proc. Natl. Acad. Sci. USA, 85:2444-2448 (1988).
Philpott et al., “Human Hair Growth in vitro: a Model for the Study of Hair Follicle Biology,”Journal of Dermatological Science, 7:S55-S72 (1994).
Sagarin,Cosmetics, Science and Technology, 2ndEdition, vol. 1, pp. 32-43 (1972).
Sarkar et al., “The “Megaprimer” Method of Site-Directed Mutagenesis,”BioTechniques, 8(4):404-407 (1990).
Sayre et al., “Physical Sunscreens,”J. Soc. Cosmet. Chem., 41(2):103-109 (1990).
Song et al., “Kunitz-type Soybean Trypsin Inhibitor Revisited: Refined Structure of its Complex with Porcine Trypsin Reveals an Insight into the Interaction Between a Homologous Inhibitor fromErythrina caffraand Tissue-type Plasminogen Activator,”J. Mol. Biol., 275:347-363 (1998).
Taylor, “The Classification of Amino Acid Conservation,”J. Theor. Biol., 119:205-218 (1986).
Tobin et al., “Plasticity and Cytokinetic Dynamics of the Hair Follicle Mesenchyme: Implications for Hair Growth Control,”The Journal of Investigative Dermatology, 120:895-904 (2003).
Toru, Imamura, Patent Abstracts of Japan, vol. 2000, No. 7, Sep. 29, 2000, and JP 2000 097938 A (Agency of Ind. Science and amp; Technol.; Pola. Chem. Ind. Inc., Apr. 7, 2000 abstract.
Tsunogae et al., “Crystallization of Bowman-Birk Type Protease Inhibitor (Peanut) and its Complex with Trypsin,”J. Biochem., 100:243-246 (1986).
Voss et al., “Crystal Structure of the Bifunctional Soybean Bowman-Birk Inhibitor at 0.28-nm Resolution. Structural Peculiarities in a Folded Protein Conformation,”Eur. J. Biochem., 242:122-131 (1996).
Werner et al., “Three-Dimensional Structure of Soybean Trypsin/Chymotrypsin Bowman-Birk Inhibitor in Solution,”Biochemistry, 31(4):999-1010 (1992).
Yavelow et al., “Bowman-Birk Soybean Protease Inhibitor as an Anticarcinogen,”Cancer Research, 43:2454s-2459s (1983).
Yavelow et al., “Nanomolar Concentrations of Bowman-Birk Soybean Protease Inhibitor Suppress X-Ray-Induced Transformation in vitro,”Proc. Natl. Acad. Sci. USA, 82:5395-5399 (1985).
Day Anthony G.
Murray Christopher J.
Power Scott D.
Rider Turnquest Beverley
Bradley Christina M.
Genencor International Inc.
Quertermous Elena E.
Tsang Cecilia J.
LandOfFree
FGF-5 supported and binding peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with FGF-5 supported and binding peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and FGF-5 supported and binding peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4093994